Boosting the Systemic and in Situ CD4+ T-Cell Responses to Malignant Glioma by Oncolytic HSV Virotherapy

Grant

Date/time Interval

  • September 1, 2018 - August 31, 2021
  • Total Award Amount

  • 527162.00
  • Direct Costs

  • 360000.00
  • Sponsor Award Id

  • W81XWH1810315
  • Contributor

  • Anita Hjelmeland Ph.D.   Investigator  
  • George Gillespie   Investigator  
  • James Markert M.D., M.P.H.   Investigator  
  • Jianmei Leavenworth Ph.D.   Principal Investigator  
  • Peng Li PhD   Investigator